Connection

Federica del Monte to Animals

This is a "connection" page, showing publications Federica del Monte has written about Animals.
Connection Strength

0.609
  1. Gene Transfer to Rodent Hearts In Vivo. Methods Mol Biol. 2017; 1521:195-204.
    View in: PubMed
    Score: 0.041
  2. Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2015 Mar 31; 65(12):1199-1214.
    View in: PubMed
    Score: 0.036
  3. Protein post-translational modifications and misfolding: new concepts in heart failure. Proteomics Clin Appl. 2014 Aug; 8(7-8):534-42.
    View in: PubMed
    Score: 0.035
  4. Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation. 2008 Aug 05; 118(6):614-24.
    View in: PubMed
    Score: 0.023
  5. Intracellular devastation in heart failure. Heart Fail Rev. 2008 Jun; 13(2):151-62.
    View in: PubMed
    Score: 0.023
  6. Targeted gene transfer in heart failure: implications for novel gene identification. Curr Opin Mol Ther. 2004 Aug; 6(4):381-94.
    View in: PubMed
    Score: 0.017
  7. Transcriptional changes following restoration of SERCA2a levels in failing rat hearts. FASEB J. 2004 Sep; 18(12):1474-6.
    View in: PubMed
    Score: 0.017
  8. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A. 2004 Apr 13; 101(15):5622-7.
    View in: PubMed
    Score: 0.017
  9. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol. 2003 Jan 01; 546(Pt 1):49-61.
    View in: PubMed
    Score: 0.016
  10. Efficient viral gene transfer to rodent hearts in vivo. Methods Mol Biol. 2003; 219:179-93.
    View in: PubMed
    Score: 0.016
  11. Dissociation of hypertrophic growth from changes in myocyte contractile function. J Card Fail. 2002 Dec; 8(6 Suppl):S415-20.
    View in: PubMed
    Score: 0.015
  12. Defects in calcium control. J Card Fail. 2002 Dec; 8(6 Suppl):S421-31.
    View in: PubMed
    Score: 0.015
  13. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation. 2001 Sep 18; 104(12):1424-9.
    View in: PubMed
    Score: 0.014
  14. The long and winding road to target protein misfolding in cardiovascular diseases. Eur J Clin Invest. 2021 May; 51(5):e13504.
    View in: PubMed
    Score: 0.014
  15. Primary cilia defects causing mitral valve prolapse. Sci Transl Med. 2019 05 22; 11(493).
    View in: PubMed
    Score: 0.012
  16. Getting to the Heart of Alzheimer Disease. Circ Res. 2019 01 04; 124(1):142-149.
    View in: PubMed
    Score: 0.012
  17. Response to letter regarding article "Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes". Circulation. 2014 May 27; 129(21):e510-1.
    View in: PubMed
    Score: 0.009
  18. Isolation, culture, and functional characterization of adult mouse cardiomyoctyes. J Vis Exp. 2013 Sep 24; (79):e50289.
    View in: PubMed
    Score: 0.008
  19. Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation. 1993 Sep; 88(3):854-63.
    View in: PubMed
    Score: 0.008
  20. Subcellular mechanism of the species difference in the contractile response of ventricular myocytes to endothelin-1. Cardioscience. 1993 Sep; 4(3):185-91.
    View in: PubMed
    Score: 0.008
  21. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol. 2013 Sep; 108(5):378.
    View in: PubMed
    Score: 0.008
  22. Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation. 2013 Sep 17; 128(12):1286-97.
    View in: PubMed
    Score: 0.008
  23. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest. 2013 Aug; 123(8):3378-82.
    View in: PubMed
    Score: 0.008
  24. Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation. 2012 Oct 30; 126(18):2208-19.
    View in: PubMed
    Score: 0.008
  25. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012 May 09; 485(7398):333-8.
    View in: PubMed
    Score: 0.007
  26. [Isolated cardiac myocytes: preparation and use in experimental cardiology]. Cardiologia. 1991 Apr; 36(4):319-29.
    View in: PubMed
    Score: 0.007
  27. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circ Res. 2011 Apr 29; 108(9):1071-83.
    View in: PubMed
    Score: 0.007
  28. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation. 2011 Mar 29; 123(12):1287-96.
    View in: PubMed
    Score: 0.007
  29. Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination. J Mol Cell Cardiol. 2011 Apr; 50(4):652-61.
    View in: PubMed
    Score: 0.007
  30. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2010 Dec; 49(6):993-1002.
    View in: PubMed
    Score: 0.007
  31. Cardiomyogenesis in the adult human heart. Circ Res. 2010 Jul 23; 107(2):305-15.
    View in: PubMed
    Score: 0.006
  32. Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am J Physiol Heart Circ Physiol. 2009 Feb; 296(2):H310-7.
    View in: PubMed
    Score: 0.006
  33. Progressive nature of chronic mitral regurgitation and the role of tissue Doppler-derived indexes. Am J Physiol Heart Circ Physiol. 2008 May; 294(5):H2106-11.
    View in: PubMed
    Score: 0.006
  34. Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J Am Coll Cardiol. 2008 Jan 29; 51(4):476-86.
    View in: PubMed
    Score: 0.006
  35. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007 Aug; 13(8):962-9.
    View in: PubMed
    Score: 0.005
  36. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol. 2007 Sep; 293(3):H1581-9.
    View in: PubMed
    Score: 0.005
  37. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther. 2007 Jul; 14(13):989-97.
    View in: PubMed
    Score: 0.005
  38. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol. 2007 Apr; 42(4):852-61.
    View in: PubMed
    Score: 0.005
  39. Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. Am J Physiol Heart Circ Physiol. 2007 Feb; 292(2):H1204-7.
    View in: PubMed
    Score: 0.005
  40. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2007 Jan; 292(1):H522-9.
    View in: PubMed
    Score: 0.005
  41. Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function. J Mol Cell Cardiol. 2006 May; 40(5):653-65.
    View in: PubMed
    Score: 0.005
  42. Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. Mol Ther. 2006 May; 13(5):987-96.
    View in: PubMed
    Score: 0.005
  43. SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr. 2005 Dec; 37(6):375-80.
    View in: PubMed
    Score: 0.005
  44. Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res. 2005 Sep 02; 97(5):488-95.
    View in: PubMed
    Score: 0.005
  45. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest. 2005 Aug; 115(8):2128-38.
    View in: PubMed
    Score: 0.005
  46. Transgenic models of heart failure: elucidation of the molecular mechanisms of heart disease. Heart Fail Clin. 2005 Jul; 1(2):219-36.
    View in: PubMed
    Score: 0.005
  47. Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol. 2005 Jun; 288(6):H2995-3000.
    View in: PubMed
    Score: 0.005
  48. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res. 2005 Apr 15; 96(7):756-66.
    View in: PubMed
    Score: 0.005
  49. Antisense strategies for treatment of heart failure. Methods Mol Med. 2005; 106:69-82.
    View in: PubMed
    Score: 0.004
  50. Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications. Expert Rev Cardiovasc Ther. 2005 Jan; 3(1):85-97.
    View in: PubMed
    Score: 0.004
  51. In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation. 2004 Nov 30; 110(22):3435-43.
    View in: PubMed
    Score: 0.004
  52. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res. 2004 Oct 01; 95(7):708-16.
    View in: PubMed
    Score: 0.004
  53. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging. 2004 Apr; 3(2):69-75.
    View in: PubMed
    Score: 0.004
  54. Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytes. Mol Cell Biochem. 2003 Sep; 251(1-2):103-9.
    View in: PubMed
    Score: 0.004
  55. Modulating signaling pathways in hypertrophy and heart failure by gene transfer. J Card Fail. 2002 Dec; 8(6 Suppl):S389-400.
    View in: PubMed
    Score: 0.004
  56. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging. 2002 Oct; 1(4):365-77.
    View in: PubMed
    Score: 0.004
  57. Titin isoform switch in ischemic human heart disease. Circulation. 2002 Sep 10; 106(11):1333-41.
    View in: PubMed
    Score: 0.004
  58. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol. 2002 Jun; 22(12):4124-35.
    View in: PubMed
    Score: 0.004
  59. Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transfer. Basic Res Cardiol. 2002; 97 Suppl 1:I136-45.
    View in: PubMed
    Score: 0.004
  60. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001 Jul 17; 104(3):330-5.
    View in: PubMed
    Score: 0.004
  61. SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes. J Mol Cell Cardiol. 2001 May; 33(5):1005-15.
    View in: PubMed
    Score: 0.003
  62. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3322-7.
    View in: PubMed
    Score: 0.003
  63. Prospects for gene therapy for heart failure. Circ Res. 2000 Mar 31; 86(6):616-21.
    View in: PubMed
    Score: 0.003
  64. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation. 2000 Feb 22; 101(7):790-6.
    View in: PubMed
    Score: 0.003
  65. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A. 2000 Jan 18; 97(2):793-8.
    View in: PubMed
    Score: 0.003
  66. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J Clin Invest. 1999 Aug; 104(4):391-8.
    View in: PubMed
    Score: 0.003
  67. Signaling pathways mediating the response to hypertrophic stress in the heart. Gene Expr. 1999; 7(4-6):337-48.
    View in: PubMed
    Score: 0.003
  68. From overload to failure: what happens inside the myocyte. Ann Med. 1998 Aug; 30 Suppl 1:14-23.
    View in: PubMed
    Score: 0.003
  69. Cyclic AMP levels in ventricular myocytes from noradrenaline-treated guinea-pigs. Eur J Pharmacol. 1996 Aug 29; 310(2-3):235-42.
    View in: PubMed
    Score: 0.002
  70. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol. 1996 Jun; 270(6 Pt 2):H2060-9.
    View in: PubMed
    Score: 0.002
  71. Activation of ATP-dependent K+ channels enhances myocardial protection due to cold high potassium cardioplegia: a force-frequency relationship study. J Mol Cell Cardiol. 1995 Sep; 27(9):1867-81.
    View in: PubMed
    Score: 0.002
  72. Decreased contractile responses to isoproterenol in isolated cardiac myocytes from aging guinea-pigs. J Mol Cell Cardiol. 1995 May; 27(5):1141-50.
    View in: PubMed
    Score: 0.002
  73. Characteristics of myocytes isolated from hearts of renovascular hypertensive guinea pigs. Am J Physiol. 1994 May; 266(5 Pt 2):H1886-95.
    View in: PubMed
    Score: 0.002
  74. [The inotropic and bathmotropic effects of beta stimulation: a study comparing dobutamine and dopamine on the guinea-pig papillary muscle in isotonic contraction]. Cardiologia. 1992 Sep; 37(9):635-9.
    View in: PubMed
    Score: 0.002
  75. Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP. Eur J Pharmacol. 1990 Nov 27; 191(2):129-40.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.